Clinical and laboratory peculiarities of combined clinical course of metabolic and articular syndromes

Cover Page

Cite item

Abstract

Aim. To identify clinical and laboratory peculiarities of a combined clinical course of metabolic and articular syndromes.

Materials and Methods. In the research 126 individuals participated. They were arranged into 3 groups: the 1st group included 46 patients with comorbid pathology, the 2nd group – 44 patients with metabolic syndrome, and the 3d group – 36 patients with articular syndrome. The following parameters were evaluated: anthropometric data (height, body mass, body mass index, waist circumference), lipid spectrum, glycohemoglobin, nonspecific markers of inflammation, daily profile of arterial pressure.

Results. In the group with comorbid pathology higher average values of body mass were recorded – 115.8 [60;140] kg in comparison with the 2nd and 3d groups – 93.5 [72;130] and 71.5 [58;98] kg, respectively; erythrocyte sedimentation rate – 18.3 [5;34] mm/h was reliably higher than in the 2nd group (11.5 [2;24] mm/h), and median cholesterol (6.18 [5,39;6,85] mmol/L) was higher than in the 3d group (4.82 [3,48;5,61] mmol/L). In the 1st and 2nd groups higher average values of systolic arterial pressure were recorded in comparison with the 3d group – 158,5 [120;190]; 154,6 [115;190] and 126,4 [96;168] mm Hg, respectively.

Conclusions. In patients with combined metabolic and articular syndromes higher values of body mass and systolic arterial pressure were identified. Based on the laboratory findings, parameters of cholesterol and erythrocyte sedimentation rate were higher in patients with comorbid condition than in those with the isolated pathologies.

About the authors

Dar'ja Yu. Gorbunova

Ryazan State Medical University

Author for correspondence.
Email: darya.solomatina.89@mail.ru
ORCID iD: 0000-0002-8232-2753
SPIN-code: 8125-8234

PhD Student of the Department of Faculty Therapy with Courses of Endocrinology, Clinical Pharmacology, Occupational Diseases

Russian Federation, 9, Vysokovoltnaja str., Ryazan, 390026

Zinaida A. Morgunova

Municipal Clinical Hospital №11

Email: darya.solomatina.89@mail.ru
ORCID iD: 0000-0002-2159-0287
SPIN-code: 4126-4049

Еndocrinologist

Russian Federation, Ryazan

Oleg M. Uryasyev

Ryazan State Medical University

Email: darya.solomatina.89@mail.ru
ORCID iD: 0000-0001-8693-4696
SPIN-code: 7903-4609

MD, Grand PhD, Professor, Head of the Department of Faculty Therapy with Courses of Endocrinology, Clinical Pharmacology, Occupational Diseases

Russian Federation, 9, Vysokovoltnaja str., Ryazan, 390026

References

  1. Chazova IE, Negoda SV, Zhernakova YuV, et al. Rekomendatsii po vedeniyu bol'nykh s metabolicheskim sindromom: klinicheskie rekomendatsii. Moscow; 2013. (In Russ).
  2. Balabanova RM, Erdes ShF. The incidence and prevalence of rheumatic diseases in Russia in 20122013. Rheumatology Science and Practice. 2015;53(2):1204. (In Russ). doi:10.14412/ 199544842015120124
  3. Ersh IR, Mironchik EV, Pelesa ES, et al. Sustavnoi sindrom: posobie dlya studentov lechebnogo fakul'teta i klinicheskikh ordinatorov. Grodno: GrGMU; 2012. (In Russ).
  4. Povoroznyuk VV, Grigor'eva NV. Differentsial'naya diagnostika i lechenie sustavnogo sindroma. Available at: http://medobuch.kz/ differencialnayadiagnostikailechenye. Accessed 9 Nov 2017. (In Russ).
  5. Gordeev AV, Galushko EA, Nasonov EL. The concept of multimorbidity in rheumatologic practice. Rheumatology Science and Practice. 2014;52(4):3624. (In Russ). doi:http://dx.doi. org/10.14412/199544842014362365
  6. Radner H, Yoshida K, Smolen JS, et al. Multimorbidity and rheumatic conditionsenhancing the concept of comorbidity. Nat Rev Rheumatol. 2014;10(4):2526. doi: 10.2331/suisan.32.804
  7. Le Reste JY, Nabbe P, Manceau B, et al. The European General Practice Research Network presents a comprehensive definition of multimorbidity in family medicine and long term care, following a systematic review of relevant literature. J Am Med Dir Assoc. 2013;14(5):31925.doi:https://doi.org/10.1016/j.jamda.2013.01.001
  8. Nabieva DA, Rizamukhamedova MZ, Mukhammadieva SM. Metabolic changes in patients with gout. Lechebnoe delo. 2016;1:525. (In Russ).
  9. Aslonova ShZh, Kosimov UU, Mavlonov NKh, et al. Moxonidine treatment and metformin metabolic syndrome. Science of Young (Eruditio Juvenium). 2015;3(3):2939. (In Russ).
  10. Korzh IV. Biokhimicheskie markery metabolizma soedinitel'noi tkani u bol'nykh osteoartrozom s arterial'noi gipertenziei i ozhireniem. Nauchnye vedomosti Belgorodskogo gosudarstvennogo universiteta. Seriya: Meditsina. Farmatsiya. 2013;154(11):3740. (In Russ).
  11. Sysoeva MS, Solov'eva AV, Nikiforova LV, et al. Izuchenie sistemnogo vospaleniya u bol'nykh bronkhial'noi astmoi v sochetanii s metabolicheskim sindromom. IP Pavlov Medical Biological Herald. 2012;20(4):1026. (In Russ). doi:http://dx.doi.org/10.17816/PAVLOV J20124102106
  12. Sergeeva VV, Rodionova AYu. Modern approach to the assessment of hypertension and metabolic disorders. Arterial'naya gipertenziya. 2013;19(5):4012. (In Russ). doi:http:// dx.doi.org/10.18705/1607419X2013195397404
  13. Bychkov OA, Bychkova NG. Immunologicheskie markery vospaleniya i ikh rol' v techenii arterial'noi gipertenzii. Universum: meditsina i farmakologiya. 2015;21(10):46. (In Russ).
  14. Eliseev MS, Chikalenkova NA, Barskova VG. Clinical features of gout in women: the results of a comparative study. Rheumatology Science and Practice. 2014;52(2):17882. (In Russ). doi: 10.14412/199544842014178182
  15. Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. Nutrients. 2013;5:121840. doi: 10.3390/nu5041218
  16. Kunitskaya NA. Features of violations of lipid metabolism in elderly patients with gout. Meditsinskie nauki. 2013;3:1069. (In Russ).
  17. Panafidina TA, Kondrat'eva LV, Gerasimova EV. Comorbidity in rheumatoid arthritis. Rheumatology Science and Practice. 2014;52(3):2839. (In Russ). doi:http://dx.doi.org/10.14412/ 199544842014283289
  18. Zinchuk IYu, Amirdzhanova VN. Social burden of rheumatoid arthritis. Rheumatology Science and Practice. 2014;52(3):3314. (In Russ). doi:http://dx.doi.org/10.14412/199544842014 331335
  19. Kondrat'eva LV, Popkova TV, Nasonov EL. Metabolic syndrome in rheumatoid arthritis: role of adiponectin (preliminary results). Rheumatology Science and Practice. 2013;51(3): 30213. (In Russ). doi:http://dx.doi.org/10. 14412/1995448420131250
  20. Covic T, Cumming SR, Pallant JF, et al. Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the depression, anxiety and stress scale (DASS) and the hospital, anxiety and depression scale (HADS). BMC Psychiatry. 2012;24(2):6. doi:https://doi.org/10.1186/1471 244X126

Copyright (c) 2018 Gorbunova D.Y., Morgunova Z.A., Uryasyev O.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies